期刊文献+

慢性阻塞性肺疾病患者的药学监护 被引量:2

Pharmaceutical Care for Patients with Chronic Obstructive Pulmonary Disease
原文传递
导出
摘要 目的探讨慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)治疗方案及药学监护的内容。方法以2007年12月收治的1例COPD患者为例,结合COPD治疗指南,为COPD急性加重期患者制定个体化的药学监护计划并实施全程的药学监护。结果患者COPD急性加重期的药物治疗方案有效合理。通过全程的药学监护,及时发现和解决了患者药物治疗的问题,为临床合理用药提供了意见。结论对COPD患者实施药学监护具有可行性和实用性。 Objective To investigate the treatment and pharmaceutical care for chronic obstructive pulmonary disease(COPD) patients.Methods In December 2007,a patient with COPD was diagnosed,and based on the clinical data,COPD treatment guidelines were adopted to analyze treatment plans.For patients with acute exacerbation of COPD,individualized pharmaceutical care plan was proposed,and pharmaceutical care was performed during the whole course of disease.Results The drug treatment for the one patient with acute exacerbation of COPD was effective and reasonable.Treatment problems were observed and solved through pharmaceutical care which had given reasonable suggestions for medication.Conclusion The implementation of pharmaceutical care for COPD patients is feasible and practical.
作者 任强 郑咏池
出处 《华西医学》 CAS 2011年第12期1853-1855,共3页 West China Medical Journal
关键词 慢性阻塞性肺疾病 药学监护 临床药师 Chronic obstructive pulmonary disease Pharmaceutical care Clinical pharmacists
  • 相关文献

参考文献7

  • 1COPD诊治指南(2007年修订版)[J].继续医学教育,2007,21(2):31-42. 被引量:366
  • 2Sethi S,Murphy TF.Infection in the pathogenesis and courseofchronic obstructive pulmonary disease[J].N Engl J Med,2008,359(22):2355-2365.
  • 3周庆涛,贺蓓.慢性阻塞性肺疾病急性加重期的抗菌药物应用——COPD指南解读[J].中国药物应用与监测,2011,8(2):65-68. 被引量:47
  • 4Seemungal TAR,Wilkinson TMA,Hurst JR,et al.Long-termerythromycin therapy is associated with decreased chronicobstructive pulmonary disease exacerbations[J].Am J RespirCrit Care Med,2008,178(11):1139-1147.
  • 5Vestbo J,Sorensen T,Lange P,et al.Long-term effect of inhaled budesonide in mile and moderate chronic obstructivepulmonary disease:a randomized controlled trial[J].Lancet,1999,353(9167):1819-1823.
  • 6Luncel Health Study Research Group.Effect of inhaledtriamcinolone on the decline in pulmonary function in chronicobstructive pulmonary disease[J].N Engl J Med,1999,343(26):1902-1909.
  • 7叶晓芬,蔡映云,吕迁洲.临床药师对住院病人如何开展药学监护[J].中国执业药师,2009,6(1):8-10. 被引量:8

二级参考文献11

  • 1师少军,陈华庭,曾繁典.药学监护研究进展[J].中国临床药理学与治疗学,2005,10(1):1-4. 被引量:17
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 3Kherad O,Kaiser L,Bridevaux PO,et al.Upper-respiratory viral infection,biomarkers,and COPD exacerbations. Chest . 2010
  • 4Hurst JR,Vestbo J,Anzueto A,et al.Susceptibility to exacerbation in chronic obstructive pulmonary disease. The New England Journal of Medicine . 2010
  • 5M Woodhead,F Blasi,S Ewig,G Huchon,M Leven,A Ortqvist,T Schaberg,A Torres,G Heijden,TJM Verheij.Guidelines for the management of adult lower respiratory tract infections. European Respiratory Journal . 2005
  • 6Seemungal TA,Wilkinson TM,Hurst JR,et al.Long-term erythro-mycin therapy is associated with decreased chronic obstructive pul-monary disease exacerbations. American Journal of Respiratory and Critical Care Medicine . 2008
  • 7Daniets J M,schoorl M,snijders D,et al.Procalctionin vs C-reactive protein as predictive markers of response to antibiotictherapy in acute exacerbations of COPD. Chest . 2010
  • 8Global Initiative for Chronic Obstructive Lung Disease.Global strategy for diagnosis,management,and prevention of COPD (DB/OL). http://www.goldcopd.org/ Guidelineitem.asp? l1=2&l2=1&intId=2003 . 2009
  • 9Sethi S,Murphy TF.Infection in the pathogenesis and course of chronic obstructive pulmonary disease. The New England Journal of Medicine . 2008
  • 10Canut A,Martin-Herrero JE,Labora A,et al.What are the most appropriate antibiotics for the treatment of acute exacer-bation of chronic obstructive pulmonary disease?A therapeutic outcomes model. Journal of Antimicrobial Chemotherapy . 2007

共引文献416

同被引文献22

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部